Latest News

 Filter by Provider

MP has the backing of the Pentagon and a potentially enormous growth opportunity ahead. Can it make patient investors rich?

Manufacturing delays have pushed back the fleet ramp, but regulatory wins and a major customer MOU suggest the path to profitability is clearing.

Margin pressure from customer mix shifts may threaten near-term profitability, even as long-term OLED expansion accelerates.

This lesser-known dividend stock offers a yield above 4% and a potentially powerful earnings growth catalyst that could help it outperform Coca-Cola and PepsiCo over the next decade.

Factory utilization in the mid-80% range and a path to 60% gross margins suggest NXP is positioned to convert structural growth into shareholder returns.

Unified branding and discounted oil-change campaigns are lifting repair traffic, helping offset pressure from vehicle affordability headwinds.

Satellite scale meets drone agility, but one company's revenue jumped 508% while the other's forward multiple tells a very different valuation story.

AT&T and Verizon both trade at similar valuations, but their paths diverge sharply in other areas.

Netflix's core competitive advantage should drive great long-term results.

Alibaba and Uber both lead their markets, but one trades at a far lower earnings multiple while the other is priced for sustained high growth.

Buffett’s wisdom is timeless.

Credo's revenue surged past 160% in the latest twelve months, but Marvell's $9.5 billion scale and heavier debt load tell a very different story for investors.

It could still get better from here.

Hotter-than-expected inflation in October means the Fed may raise its target rate by a half percentage point next month.

Novo Nordisk's obesity-drug dominance faces rising rivals, while Pfizer's cheaper valuation and cash flow tell a different story for income-minded investors.

Michael Saylor just floated up to $30 billion in new financing for Strategy. Here's what that number does and doesn't mean.

AGNC’s book value plunged 17% in one quarter, yet its 17.5%-yielding dividend didn’t budge. Here’s why the payout looks safe for now.

Arm and ASML sit at opposite ends of the chip supply chain, but a sharp gap in their valuations may tip the scales for cautious buyers.

Synopsys earns nearly $1.3 billion in net income on $7.1 billion in revenue, while SentinelOne is still posting a net loss despite 21.9% growth.

Component shortages are holding back shipments, so near-term revenue depends on securing parts rather than on demand alone.

Arista's margins are running hot, but IBM's steady software pivot and far lower valuation make the 2027 choice closer than the price tags suggest.

Only seven past stretches since 1950 lasted this long. Did a tough year normally follow?

Innodata's revenue jumped nearly 47% while Nebius posted a far steeper climb, but their valuations and risk profiles tell very different stories.

D-Wave Quantum grew third-quarter revenue 21%, but its stock trades at a steep multiple. Here is how far it would need to grow to match IonQ's size.

The $1.3 billion liquidity cushion gives the company room to scale production without dilutive financing, but integrating facilities across eight states will test that discipline.

Realty Income's 5.4% yield isn't paid quarterly, which can change everything if you are trying to live off your dividend income.

Axsome's revenue has climbed about 54% while Moderna's net losses run deep, but a steep valuation gap may tip the scales for patient investors.

It’s been a turbulent week for Nvidia.

There are several reasons your checks might be smaller than you expected, and they're not all problems.

Firefly's $1.4 billion backlog and Redwire's 45.8% revenue growth point to very different bets, and the valuation gap may be the deciding factor.

Having the right information could make your RMDs more manageable.

Alibaba's profitability stands in stark contrast to Coupang's losses, but the valuation gap between these two regional giants may be the more telling story.

C3.ai's revenue fell sharply over the past year while SentinelOne kept expanding, but their valuations tell very different stories for investors.

Recent stumbles from some of the market's biggest leading growth names suggest a shift may be brewing.

CoreWeave stock jumped after delivering strong revenue growth.

MercadoLibre's 47% revenue surge stands out, but Uber's cheaper earnings multiple and steadier balance sheet make the 2027 call far closer than the growth numbers suggest.

Buffett said that hesitating over a small price gap on Walmart cost Berkshire about $10 billion. Here’s how to avoid the same trap.

More volatility could be coming, but history still has promising news for investors.

Oracle's AI opportunity is hard to ignore, but financing that growth comes at a price. I examine the numbers, risks, and milestones that could determine what happens next.

Wall Street expects the hyperscalers to keep up their heavy capital expenditures, but it's worried that the revenue growth they are expecting to result from that spending might not show up.

Trying to time the market usually damages your portfolio's returns.

With up to $40 billion in spending already planned for this quarter, how will the rocket and AI company pay for its new campuses?

Warren Buffett liked to buy and hold, which could be a good call with Coca-Cola, P&G, and, for the more aggressive, Kimberly Clark.

CoreWeave can become a multibagger over the coming year owing to its red-hot growth and cheap valuation.

Although Nvidia stock hasn’t been this fundamentally cheap in a long time, a mountain of risks far outweigh the reward.

The most popular alternative is riskier than it looks.